Skip to main content
. 2020 Jul 7;9(14):e017529. doi: 10.1161/JAHA.120.017529

Figure 4.

Figure 4

Drug‐drug interactions between antiarrhythmic drugs/anticoagulants in atrial fibrillation (AF) and emerging coronavirus disease 2019 (COVID‐19) pharmacotherapies. AAD indicates antiarrhythmic drug; CYP, cytochrome P; DOAC, direct oral anticoagulant; and IKr, potassium channel.